Tag Archives: PrEP

Gilead’s Descovy nabs PrEP nod. Next step: Convert Truvada patients before generics hit

Clock’s ticking. After an expected FDA nod for Descovy as the second HIV PrEP drug, Gilead Sciences now has one year to convince its current Truvada takers to switch over before generics hit. The FDA approval is for Descovy use in men and transgender women for HIV prevention. The exclusion of cisgender women from the label… Read More »

Transgender women tell researchers how to increase the uptake of PrEP in their community

Transgender women and transfeminine nonbinary individuals suggested a number of key issues that health services need to address in order to increase the uptake of pre-exposure prophylaxis (PrEP) among transgender people. These included addressing the contextual factors associated with HIV in this community, developing more inclusive messaging and imagery, healthcare providers having an ongoing dialogue… Read More »

How did Kenya build Africa’s largest PrEP programme?

Around 25000 people are taking PrEP in Kenya, making it Africa’s largest PrEP programme, ahead of South Africa (9000 people), Uganda (4000) and Zimbabwe (4000). The rollout was recently described by officials from Kenya’s Ministry of Health in the journal Sexual Health and also at October’s HIV Research for Prevention conference. Overall 5.6% of Kenya’s… Read More »

PrEP promotion should be positive

The editors of the Lancet HIV contrast Dr K Rivet Amico and Professor Linda-Gail Bekker’s recommendations with the current state of PrEP policy in England. PrEP is only available through the Impact trial, which has been oversubscribed by gay and bisexual men, with capacity reached in many clinics and potential participants turned away. A proposal to… Read More »

HIV infections among black gay men taking PrEP, probably due to poor adherence

Awareness and use of HIV pre-exposure prophylaxis (PrEP) among black gay, bisexual and other men who have sex with men (MSM) in the United States increased significantly between 2014 and 2017, according to research published in the 1 November edition of the Journal of Acquired Immune Deficiency Syndromes. The study also showed that PrEP was… Read More »